drugset / Trial / NCT02033018
Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the clinical results of anti-VEGF intra-vitreal injections (IVT) in CNV secondary
Timeline
- Start
- 2013-10
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aflibercept | Protein / enzyme biologic | 0.5 mg | Intravitreal |